glp-1 medication shortage Diabetes Patients Also Struggle to Access Agonists FDA says that the GLP-1

( c ) Lipidomic profiling of small-intestinal crypts from WT and iOE mice on CD

This high metabolic demand renders ocular tissues particularly vulnerable to metabolic dysregulation, which can precipitate an energy crisis leading to retinopathy, AMD, and other pathologies

Semaglutide taps into one channel of that system

15 demonstrating powerful inhibition of food intake after ICV administration of GLP-1, an effect that could be blocked by the specific receptor antagonists exendin 939, which also enhanced spontaneous as well as neuropeptide Y-stimulated food intake

doi: 10.3389/fnut.2022.931458 26 Blecharz-LangK

Steed H, Walsh S, Reynolds N